Carbachol, substance P, and phorbol ester promote the tyrosine phosphorylation of protein kinase C delta in salivary gland epithelial cells.
The initiation of saliva formation by parotid acinar cells, which comprise the majority of cells in this salivary gland, is initiated by the release of neurotransmitters (acetylcholine, substance P) from parasympathetic nerves. In response to substance P and the muscarinic agonist carbachol, two ligands that activate phospholipase C-linked receptors, which stimulate fluid secretion, PKC delta was phosphorylated on tyrosine residues. The maximal agonist-dependent tyrosine phosphorylation occurred within seconds of the addition of either agonist and then returned rapidly to a smaller increased level. Phorbol ester also caused a rapid increase in tyrosine phosphorylation, which reached a maximal level 5 min after the addition of phorbol 12-myristate 13-acetate. The increase in tyrosine phosphorylation of PKC delta was blocked by tyrosine kinase inhibitors genistein and staurosporine. Ionophore-mediated elevation of [Ca2+]i or activation of the beta-adrenergic receptor, epidermal growth factor receptor, or insulin receptor did not promote the tyrosine phosphorylation of PKC delta. These results indicate that tyrosine phosphorylation plays a role in early signal transduction events promoted by the activation of muscarinic and substance P receptors and suggests that the tyrosine phosphorylation of PKC delta has a role in the activation of fluid secretion by neurotransmitters binding to phospholipase C-linked receptors.
Soltoff
S P
SP
Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02115, USA.
Toker
A
A
D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport; D002217:Carbachol / Q000494:pharmacology*; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D004789:Enzyme Activation; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects / Q000201:enzymology; D066246:ErbB Receptors / Q000502:physiology; D019833:Genistein; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007529:Isoflavones / Q000494:pharmacology; D010766:Phosphorylation; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051745:Protein Kinase C-delta; D051381:Rats; D011972:Receptor, Insulin / Q000037:antagonists & inhibitors / Q000502:physiology; D012469:Salivary Glands / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D019311:Staurosporine; D013373:Substance P / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014443:Tyrosine / Q000378:metabolism*
D000470:Alkaloids; D007527:Isoenzymes; D007529:Isoflavones; D013373:Substance P; D014443:Tyrosine; D002217:Carbachol; D019833:Genistein; C497260:Prkcd protein, rat; D066246:ErbB Receptors; D011972:Receptor, Insulin; D011493:Protein Kinase C; D051745:Protein Kinase C-delta; D019311:Staurosporine; D013755:Tetradecanoylphorbol Acetate